News and Stories
November 7, 2019 | U of T engineering have chatted with Locke Davenport Huyer (ChemE, IBBME PhD 1T9) about his research topic in graduate school.
October 31, 2019 | In conversation with Dr. José Zariffa on how the field could address conditions from Alzheimer’s disease to vision loss.
October 25, 2019 | Interface Biologics’s (IBI) antithrombogenic additive have been used in a new line of FDA-approved “breakthrough” dialysis products made by IBI’s partner, Fresenius Medical Care.
October 8, 2019 | Professor Milica Radisic (Institute of Biomaterials and Biomedical Engineering, Chemical Engineering), Professor Boyang Zhang (IBBME Alumni), and Dr. Yimu Zhao (Chemical Engineering, IBBME) had been awarded the 2019 Innovation & Commercialization Award by Tissue Engineering International & Regenerative Medicine Society (TERMIS).
September 11, 2019 | Accounting for sex differences could be key for the development of better treatments as drug shows promise for brain repair in females only.
September 5, 2019 | Multidisciplinary team awarded five year, $1M project grant to develop a new filling material